Yan, L., Qu, S., Shang, J., Shi, X., Kang, L., Xu, N., . . . Fu, C. (2020). Sequential CD19 and BCMA‐specific CAR T‐cell treatment elicits sustained remission of relapsed and/or refractory myeloma. Cancer Med.
Dyfyniad Arddull ChicagoYan, Lingzhi, et al. "Sequential CD19 and BCMA‐specific CAR T‐cell Treatment Elicits Sustained Remission of Relapsed And/or Refractory Myeloma." Cancer Med 2020.
Dyfyniad MLAYan, Lingzhi, et al. "Sequential CD19 and BCMA‐specific CAR T‐cell Treatment Elicits Sustained Remission of Relapsed And/or Refractory Myeloma." Cancer Med 2020.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.